NCODA Logo

Ovarian Cancer: PARP Inhibitor Eligibility

Written by: Martina Fraga, PharmD Download Here Description: The purpose of this PQI is to highlight effective practices to ensure ovarian cancer patients are identified, tested, tracked, and offered a PARP inhibitor when appropriate. Background: In gynecologic cancer...

Drug Induced Hand‐Foot Syndrome

Written by: Jonas Congelli, RPh Hematology Oncology Associates of CNY Download Here Description: To discuss prevention and management of Hand-Foot Syndrome. Background: Palmar-plantar erythrodysesthesia, also known as hand-foot syndrome (HFS) is a widely recognized...